Monte Rosa Therapeutics (GLUE) Stock Chart & Stock Price History $4.38 +0.15 (+3.55%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.38 0.00 (-0.11%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monte Rosa Therapeutics Stock Price Performance The Monte Rosa Therapeutics (GLUE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 11.17%, with a year-to-date return of -36.89%. In the past month, the stock has decreased 17.20%, reflecting recent market activity. As of the latest close, Monte Rosa Therapeutics traded at $4.38 with a market cap of $269.41 million and volume of 404,889 shares. Receive GLUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.25%1 Month Performance-17.20%3 Month Performance+6.57%Year-To-Date Performance-36.89%1 Year Performance+11.17% GLUE Stock Chart for Saturday, August, 9, 2025 GLUE Chart by TradingView Monte Rosa Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$4.23$4.38+3.55%$4.40$4.12404,889 shs$269.41 million08/07/2025$4.38$4.23-3.42%$4.37$4.16426,866 shs$260.19 million08/06/2025$4.83$4.38-9.32%$4.83$4.32461,837 shs$269.41 million08/05/2025$4.88$4.83-1.02%$4.94$4.78294,267 shs$297.09 million08/04/2025$4.79$4.88+1.88%$4.98$4.75297,064 shs$300.17 million08/01/2025$4.95$4.79-3.23%$4.97$4.78578,534 shs$294.63 million07/31/2025$5.58$4.95-11.29%$5.64$4.82601,409 shs$304.47 million07/30/2025$5.26$5.58+6.08%$5.61$5.31627,092 shs$343.23 million07/29/2025$5.55$5.26-5.23%$5.60$5.22371,653 shs$323.54 million07/28/2025$5.67$5.55-2.12%$5.77$5.50454,713 shs$341.38 million Get the Latest News and Ratings for GLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$5.71$5.67-0.70%$5.79$5.50236,003 shs$348.76 million07/24/2025$5.96$5.71-4.19%$5.92$5.64479,776 shs$351.22 million07/23/2025$5.66$5.96+5.30%$6.06$5.56480,531 shs$366.60 million07/22/2025$5.83$5.66-2.92%$5.88$5.45491,585 shs$348.15 million07/21/2025$5.94$5.83-1.85%$6.25$5.80406,872 shs$358.60 million07/18/2025$5.90$5.94+0.68%$6.19$5.85528,084 shs$365.37 million07/17/2025$5.61$5.90+5.17%$5.94$5.61392,238 shs$362.91 million07/16/2025$5.23$5.61+7.27%$5.75$5.29777,558 shs$345.07 million07/15/2025$5.26$5.23-0.57%$5.35$5.10460,720 shs$321.70 million07/14/2025$5.16$5.26+1.94%$5.31$5.13382,704 shs$323.54 million07/11/2025$5.26$5.16-1.90%$5.29$5.11237,425 shs$317.39 million07/10/2025$5.29$5.26-0.57%$5.40$5.15370,484 shs$323.54 million07/09/2025$5.06$5.29+4.55%$5.31$5.08548,856 shs$325.39 million07/08/2025$4.97$5.06+1.81%$5.13$4.94484,108 shs$311.24 million Related Companies CVAC Stock Price Chart NTLA Stock Price Chart CALT Stock Price Chart HROW Stock Price Chart PRAX Stock Price Chart PAHC Stock Price Chart PHVS Stock Price Chart SYRE Stock Price Chart GPCR Stock Price Chart AVDL Stock Price Chart Receive GLUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLUE) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monte Rosa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monte Rosa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLUE Stock Alerts